These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6210631)

  • 1. The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction.
    Palacios R; Claesson L; Möller G; Peterson PA; Möller E
    Immunogenetics; 1982; 15(4):341-56. PubMed ID: 6210631
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of individual chains of HLA-DR antigens in activation of T cells induced by alloantigens.
    Palacios R
    Immunogenetics; 1981; 14(3-4):309-22. PubMed ID: 6460691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigens render interleukin-2-producer T lymphocytes sensitive to interleukin-1.
    Palacios R
    Scand J Immunol; 1981 Sep; 14(3):321-6. PubMed ID: 6173920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA-DR antigens with the autologous mixed lymphocyte reaction.
    Davey FR; Kurec AS; Dock NL; Hubbell C; Falen SW
    Tissue Antigens; 1984 Aug; 24(2):98-106. PubMed ID: 6238447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
    Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
    Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against HLA-DR antigens acting on stimulator cells prevent OKT8+ T lymphocytes from acquiring sensitivity to interleukin 2 and expressing suppressor function.
    Palacios R; Guy K; Van Heyningen V
    Eur J Immunol; 1983 Jan; 13(1):64-72. PubMed ID: 6219882
    [No Abstract]   [Full Text] [Related]  

  • 9. Alloactivated HLA class II-positive T-cell lines induce IL-2 reactivity but lack accessory cell function in mixed leukocyte culture.
    Odum N; Dickmeiss E; Hofmann B; Jakobsen BK; Morling N; Platz P; Ryder LP; Geisler C; Svejgaard A
    Hum Immunol; 1989 Jun; 25(2):135-48. PubMed ID: 2525543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an autologous mixed lymphocyte reaction account for the "spontaneous" proliferative activity of peripheral blood mononuclear cells?
    Palacios R; Fernandez C
    Cell Immunol; 1982 Mar; 68(1):173-80. PubMed ID: 6211251
    [No Abstract]   [Full Text] [Related]  

  • 12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HLA-DR and HLA-DQ products in T lymphocyte activation and in contributing to "Dw specificities".
    Bach FH; Reinsmoen NL
    Hum Immunol; 1986 Jul; 16(3):271-5. PubMed ID: 2424876
    [No Abstract]   [Full Text] [Related]  

  • 14. Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation.
    Nuñez G; Ball EJ; Myers LK; Stastny P
    Immunogenetics; 1985; 22(1):85-91. PubMed ID: 3160658
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction.
    Palacios R; Möller G
    Cell Immunol; 1981 Sep; 63(1):143-53. PubMed ID: 6456072
    [No Abstract]   [Full Text] [Related]  

  • 16. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
    Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
    Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
    Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
    Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR.
    Hirschberg H; Braathen LR; Thorsby E
    Immunol Rev; 1982; 66():57-77. PubMed ID: 6215331
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions.
    Indiveri F; Scudeletti M; Pierri I; Traverso A; Cerri C; Ferrone S
    Cell Immunol; 1986 Jan; 97(1):197-203. PubMed ID: 2943425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.